Author Topic: Rani Therapeutics' $73 Million IPO Will Fund Upcoming Clinical Trials  (Read 6 times)

kafa88

  • Newbie
  • *
  • Posts: 32
    • View Profile



Rani Therapeutics, a San Jose company that is developing drugs to replace medical injections. released to the public on Friday. เกมสล็อต

According to filings, S-1 expects its share price to be between $14 and $16 last week. on friday Shares fell slightly, at about $11. Rani raised about $73 million in initial launch.

Rani's debut comes amid turbulent IPO activity in the therapeutic field. In 2020, 71 biotechnology companies were listed on the stock exchange. By 2021, 59 companies are offering IPOs, and more are on the way. Just one day on the 30th of July Eight biotech companies are expected to start trading, including Rani Therapeutics.

Rani Therapeutics, as founder Mir Imran said, The decision to go public was partially backed by the results of a Phase I study, which provides preliminary evidence that RaniPill, the company's main product, is "in the light of the world". can be brought into the clinic